Zopiclone
SIGMA/Z4900
Synonym: 4-
CAS Number: 43200-80-2
Empirical Formula (Hill Notation): C17H17ClN6O3
Molecular Weight: 388.81
EC Number: 256-138-9
MDL Number: MFCD00133931
Linear Formula: C17H17ClN6O3
Product Type: Chemical
drug control | USDEA Schedule IV; psychotrope (France); regulated under CDSA - not available from Sigma-Aldrich Canada |
InChI | 1S/C17H17ClN6O3/c1-22-6-8 |
InChI key | GBBSUAFBMRNDJC-UHFFFAOYSA |
originator | Dainippon Sumitomo |
Quality Level | 200 |
SMILES string | CN1CCN(CC1)C(=O)OC2N(C(=O |
solubility | DMSO: 2 mg/mL |
H2O: insoluble |
Biochem/physiol Actions: | Benzodiazepine receptor agonist |
Features and Benefits: | This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
Features and Benefits: | This compound is featured on the GABAA Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
Features and Benefits: | This compound was developed by Dainippon Sumitomo . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
Other Notes: | Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. Z4900.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin. |
Symbol | GHS07 |
Signal word | Warning |
Hazard statements | H302 - H336 |
Precautionary statements | P301 + P312 + P330 |
Hazard Codes | Xn |
Risk Statements | 20/21/22-36/37/38-62 |
Safety Statements | 26-36 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
UNSPSC | 12352200 |